StockNews.com Begins Coverage on TherapeuticsMD (NASDAQ:TXMD)

Equities research analysts at StockNews.com started coverage on shares of TherapeuticsMD (NASDAQ:TXMD) in a report released on Tuesday. The firm set a “hold” rating on the stock.

TherapeuticsMD Trading Up 5.9 %

TXMD stock traded up $0.06 during mid-day trading on Tuesday, hitting $0.98. 26,069 shares of the company were exchanged, compared to its average volume of 152,325. TherapeuticsMD has a 12-month low of $0.70 and a 12-month high of $2.44. The business has a fifty day simple moving average of $0.96 and a 200-day simple moving average of $1.24.

TherapeuticsMD Company Profile

TherapeuticsMD, Inc operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors.